Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Bioscience (Scholar Edition)|January 2, 2013
Insulin-like growth factor receptor type I as a target for cancer therapyNathalie Corvaia, Alain Beck, Véronique Caussanel, et al.
Nature Reviews. Drug Discovery|March 18, 2017
Strategies and challenges for the next generation of antibody-drug conjugatesAlain Beck, Liliane Goetsch, Charles Dumontet, et al.
Biochemical Society Transactions|March 25, 2011
Tetraspanin CD151 as a target for antibody-based cancer immunotherapyJean-François Haeuw, Liliane Goetsch, Christian Bailly, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2007
Functional responses and in vivo anti-tumour activity of h7C10: a humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptorsGiuseppe Pandini, Thierry Wurch, Barbara Akla, et al.
Discovery Medicine|November 2, 2010
The next generation of antibody-drug conjugates comes of ageAlain Beck, Jean-François Haeuw, Thierry Wurch, et al.
Medecine Sciences : M/S|December 29, 2009
[The potential of monoclonal antibodies in cancer : established trastuzumab and cetuximab and promising targets IGF-1R and c-MET]Alexandre Bodmer, Liliane Goetsch, Laurence Favet, et al.
Clinical and Diagnostic Laboratory Immunology|January 11, 2003
Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148Liliane Goetsch, Jean Francois Haeuw, Thierry Champion, et al.
Vaccine|December 13, 2002
Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategiesPascale Jeannin, Giovanni Magistrelli, Liliane Goetsch, et al.
European Journal of Immunology|January 28, 2003
Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organsPascale Jeannin, Giovanni Magistrelli, Nathalie Herbault, et al.
International Journal of Cancer|September 24, 2004
A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenograftsLiliane Goetsch, Alexandra Gonzalez, Olivier Leger, et al.
Pageof 4